169 related articles for article (PubMed ID: 7305456)
1. [Toxicological and pharmacological studies on a new drug: pirfibrate (EL-466) (author's transl)].
de la Fuente R; Santos M
Arch Farmacol Toxicol; 1980 Dec; 6(3):255-64. PubMed ID: 7305456
[No Abstract] [Full Text] [Related]
2. [Hypolipidemic activity of glycine and its derivatives].
Ryzhenkov VE; Molokovskiĭ DS; Ioffe DV
Vopr Med Khim; 1984; 30(2):78-80. PubMed ID: 6740998
[TBL] [Abstract][Full Text] [Related]
3. [Biochemical and experimental aspects of the lipid-lowering drugs pharmacology (author's transl)].
Jacotot B
Sem Hop; 1979 Dec 8-15; 55(41-42):1947-55. PubMed ID: 231322
[TBL] [Abstract][Full Text] [Related]
4. HCG 004, a new highly potent hypolipidaemic drug.
Granzer E; Nahm H
Arzneimittelforschung; 1973 Sep; 23(9):1353-4. PubMed ID: 4801238
[No Abstract] [Full Text] [Related]
5. [Fenofibrate: animal toxicology in relation to side-effects in man (author's transl)].
Blane GF; Pinaroli F
Nouv Presse Med; 1980 Dec; 9(49):3737-46. PubMed ID: 7208340
[TBL] [Abstract][Full Text] [Related]
6. [Hypolipidemic effect of the new diprophylline derivative, [2-hydroxy-3-(theophylline-7-ol] propyl ester of 4-benzylhydroxybenzoic acid].
Ryzhenkov VE; Chistiakova AM; Wójcicki J; Samochowiec L; Daday R
Vopr Med Khim; 1988; 34(4):109-12. PubMed ID: 3195124
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of the antilipaemic potential of etofylline clofibrate, its metabolites and clofibrate in dietary-induced hyperlipidaemia in the rat (author's transl)].
Sterner W; Chibanguza G; Metz G
Arzneimittelforschung; 1980; 30(11b):2038-41. PubMed ID: 7194056
[TBL] [Abstract][Full Text] [Related]
8. [Pharmacology and toxicology of etofylline clofibrate].
Sterner W; Korn WD
Arzneimittelforschung; 1980; 30(11b):2023-31. PubMed ID: 7194053
[TBL] [Abstract][Full Text] [Related]
9. [Comparative study of the effects of probucol, fenofibrate and clofibrate on liver ultrastructure in rats (author's transl)].
Barnard SD; Molello JA; Caldwell WJ; Lebeau JE
Nouv Presse Med; 1980 Oct; 9(40):3005-7. PubMed ID: 7443440
[TBL] [Abstract][Full Text] [Related]
10. [Toxicological investigation of reproterol (author's transl)].
Habersang S; Leuschner F; von Schlichtegroll A
Arzneimittelforschung; 1977; 27(12):45-52. PubMed ID: 576831
[TBL] [Abstract][Full Text] [Related]
11. [Study of a new hypolipemic agent, 1-10(hydroxy-ethyl-thio) decane: LL1558. I. Toxicological and pharmacological study].
Assous E; Pouget M; Nadaud J; Tartary G; Henry M; Duteil J
Therapie; 1972; 27(3):395-411. PubMed ID: 4655207
[No Abstract] [Full Text] [Related]
12. Synthesis and pharmacological study of antihyperlipaemic activity of 2-substituted thieno(2,3-d)pyrimidin-4(3H)-ones.
Shishoo CJ; Devani MB; Bhadti VS; Jain KS; Rathod IS; Goyal RK; Gandhi TP; Patel RB; Naik SR
Arzneimittelforschung; 1990 May; 40(5):567-72. PubMed ID: 2383297
[TBL] [Abstract][Full Text] [Related]
13. [Hypolipidaemic agents (author's transl)].
Tillement JP; Albengres E; Choisy H; Millart H
Nouv Presse Med; 1980 Oct; 9(40):2947-50. PubMed ID: 7443428
[TBL] [Abstract][Full Text] [Related]
14. Potential hypolipidemic agents. XVII. Synthesis and plasma lipid-lowering properties of compounds related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate and ethyl 2-(4-chlorophenoxy)-2-methylpropionate.
Högberg T; Bondesson G; Stjernström NE
Acta Pharm Suec; 1977; 14(2):149-60. PubMed ID: 906832
[No Abstract] [Full Text] [Related]
15. Potential hypolipidemic agents. XIV. Synthesis and plasma lipid-lowering properties of substituted biphenyls, diphenyl ethers and benzofurans related to ethyl 2-(4-dibenzofuranyloxy)-2-methylpropionate.
Bondesson G; Högberg T; Misiorny A; Stjernström NE
Acta Pharm Suec; 1976; 13(2):97-106. PubMed ID: 937013
[No Abstract] [Full Text] [Related]
16. Toxicological studies on gemfibrozil.
Kurtz SM; Fitzgerald JE; Fisken RA; Schardein JL; Reutner TH; Lucas JA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):15-23. PubMed ID: 828262
[No Abstract] [Full Text] [Related]
17. Antilipidemic drugs. Part 2: Experimental study of a new potent hypolipidemic drug, isopropyl-[4'-(p-chlorobenzoyl)-2-phenoxy-2-methyl]-propionate (LF178).
Gurrieri J; Lous ML; Renson FJ; Tourne C; Voegelin H; Majoie B; Wüfert E
Arzneimittelforschung; 1976; 26(5):889-94. PubMed ID: 989363
[TBL] [Abstract][Full Text] [Related]
18. [Effect of pyridinolcarbamate on serum and vascular wall lipids in the rabbit].
Sanmald R; Wagener H; Schlierf G; Dornbusch T; Sann E
Verh Dtsch Ges Inn Med; 1972; 78():1230-2. PubMed ID: 4665504
[No Abstract] [Full Text] [Related]
19. [A clofibric acid derivative with hypolipemic and platelet antiaggregant action].
Dănilă G; Nechifor M; Filip M; Păduraru I; Ifrim C; Grădinariu D; Papa V; Manolescu A; Bădescu A
Rev Med Chir Soc Med Nat Iasi; 1988; 92(1):127-32. PubMed ID: 3393745
[No Abstract] [Full Text] [Related]
20. [Toxicology of dilazep, a new coronary active agent].
Abel HH; Brock N; Lenke D
Arzneimittelforschung; 1972 Apr; 22(4):667-74. PubMed ID: 5068245
[No Abstract] [Full Text] [Related]
[Next] [New Search]
